MARIE CASNE: Open Payments
NPI 1194456384 · HURRICANE, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 36 payments from 12 companies in 2025. Trend: 2023 $1,198 · 2024 $1,023 · 2025 $795
Food & beverage: $795
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $154 |
| ABBVIE INC. | 9 | $151 |
| Alkermes, Inc. | 6 | $129 |
| Neurocrine BioSciences, Inc. | 1 | $67 |
| Janssen Pharmaceuticals, Inc | 4 | $66 |
| Teva Pharmaceuticals USA, Inc. | 4 | $64 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Tris Pharma Inc | 1 | $23 |
Products named: FANAPT, VRAYLAR, ARISTADA, INGREZZA, INVEGA SUSTENNA, AUSTEDO XR, REXULTI, LYBALVI.
Industry payments across WV — which companies pay providers there.
